In Pharma-Factory, six different plant molecular farming platforms including whole plants, algae, hairy roots and plant cell culture will be developed by SMEs working alongside academic partners. These developments will lead to shortened production cycles and increased product yields, and ultimately lower product cost to the end-users.
Plant Molecular Farming platforms provide unique opportunities as a result of specific features of the expression systems.

The global market for bioengineered protein drugs was $172.5 billion in 2016 and it is expected to reach
$228.4 billion by 2021. 

Future jobs: Pharmer

Professor Julian Ma from St. George’s University of London describes the potential of Molecular Farming.

Molecular Farming
against AIDS

Professor Paul Christou from University of Lleida, Catalonia, Spain describes how Molecular Farming could make a difference in the fight against HIV.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 774078.

Pharma Factory copyright 2018

Terms of Service

Privacy Policy